Heart failure (HF) is increasing at an alarming rate, primary due to the rising in aging, obesity
and diabetes. Notably, individuals with type 1 diabetes (T1D) face a significantly elevated …

Background: Thinking about greater adherence to dietary planning, it is extremely important
to be aware of all nutritional strategies and dietary prescriptions available in the literature …

Atherosclerosis stands out as one of the leading causes of global mortality. The
inflammatory response against vascular wall components plays a pivotal role in the …

Abstract Purpose of Review The objective of this manuscript is to examine the current
literature on the epidemiology of metabolic dysfunction-associated steatotic liver disease …

Objective To investigate the incidence of cardiovascular disease (CVD) overall and by age,
sex, and socioeconomic status, and its variation over time, in the UK during 2000-19. Design …

Background The atherogenic index of plasma (AIP) and cardiovascular disease (CVD) in
participants with abnormal glucose metabolism have been linked in previous studies …

Heart failure with preserved ejection fraction (HFpEF) has a high prevalence, affecting more
than 50% of patients with heart failure. HFpEF is associated with multiple comorbidities, and …

The concept of “type 3 diabetes” has emerged to define alterations in glucose metabolism
that predispose individuals to the development of Alzheimer's disease (AD). Novel evidence …

Introduction Atherosclerotic cardiovascular disease (ASCVD) and heart failure (HF) are two
major complications of type 2 diabetes (T2DM). Cardiovascular protection is a key objective …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …